Brug af teknologi til at reducere unges stofbrug (TEXT2)
The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The study will demonstrate how delivery of motivational/coaching messages to justice-involved youth and their caregivers will lead to greater youth substance use treatment attendance and engagement. The study will start with identifying the feasibility and acceptability of the SMS text-messaging intervention with community-supervised justice-involved youth. Then, the study will determine whether the tailored dyadic (youth and caregiver) "SMS text-messaging plus" intervention (appointment reminder texts plus motivational message texts) improves youth substance use or dual diagnosis treatment attendance and engagement relative to the "SMS text messaging" comparison (only appointment reminder texts). Finally, the study will characterize patterns of key justice and behavioral health system-level factors that promote or hinder eventual adoption and sustainability of mHealth technology as a tool to improve treatment attendance for justice-involved youth.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
San Francisco, California, Forenede Stater, 94131
- UCSF Zuckerberg San Francisco General Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- English-speaking youth with willing adult caregiver
- Ages 13-18
- Justice-involved while living in the community
- Own a mobile phone or tablet
- Are willing to send and receive text messages
- Are referred to community-based substance use and/or mental health treatment
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: SMS Text Messaging Plus
SMS text messaging intervention for a period of 90 days to encourage attendance at community-based substance use or dual diagnosis treatment appointments through treatment appointment reminders plus motivational messages |
SMS text messaging intervention for a period of 90 days to encourage attendance at community-based substance use or dual diagnosis treatment appointments through treatment appointment reminders plus motivational messages |
|
Aktiv komparator: SMS Text Messaging
SMS text messaging intervention for a period of 90 days that included only treatment appointment reminders |
SMS text messaging intervention for a period of 90 days that included only treatment appointment reminders |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Treatment Attendance
Tidsramme: 90 days post baseline
|
Youth's percentage of treatment sessions attended as separately self-reported by youth and caregivers. |
90 days post baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Alcohol Use
Tidsramme: 90 days post baseline
|
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use. These data represent the number of youth who endorsed any alcohol use in the past 90 days |
90 days post baseline
|
|
Drug Use
Tidsramme: 90 days post baseline
|
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use. These data represent the number of youth who endorsed any drug use in the past 90 days |
90 days post baseline
|
|
Tobacco Use
Tidsramme: 90 days post baseline
|
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use. These data represent the number of youth who endorsed any tobacco use in the past 90 days |
90 days post baseline
|
|
In Mental Health Treatment at 90 Day Follow up
Tidsramme: 90 days post baseline
|
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending. |
90 days post baseline
|
|
In Substance Use Treatment at 90 Day Follow up
Tidsramme: 90 days post baseline
|
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending. |
90 days post baseline
|
|
In Dual Diagnosis (Mental Health and Substance Use) Treatment at 90 Day Follow up
Tidsramme: 90 days post baseline
|
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending. |
90 days post baseline
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Marina Tolou-Shams, PhD, University of California, San Francisco
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 1K24DA046569-01A1 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .